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SUMMARY 
Local mRNA translation mediates the adaptive responses of axons to extrinsic signals but 
direct evidence that it occurs in mammalian CNS axons in vivo is scant. We developed an 
axon-TRAP-RiboTag approach in mouse that allows deep-sequencing analysis of ribosome-
bound mRNAs in the retinal ganglion cell axons of the developing and adult retinotectal 
projection in vivo. The embryonic-to-postnatal axonal translatome comprises an evolving 
subset of enriched genes with axon-specific roles suggesting distinct steps in axon wiring, 
such as elongation, pruning and synaptogenesis. Adult axons, remarkably, have a complex 
translatome with strong links to axon survival, neurotransmission and neurodegenerative 
disease. Translationally co-regulated mRNA subsets share common upstream regulators, 
and sequence elements generated by alternative splicing promote axonal mRNA translation. 
Our results indicate that intricate regulation of compartment-specific mRNA translation in 
mammalian CNS axons supports the formation and maintenance of neural circuits in vivo.  
  
3 
INTRODUCTION 
RNA localization and local translation are evolutionarily conserved mechanisms employed by 
cells to control the precise subcellular positioning of nascent proteins. Neurons are highly 
compartmentalized cells with functionally distinct cytoplasmic/membrane domains (dendrites, 
axons, and somas), and emerging evidence indicates that localized mRNA translation 
supports this subcellular differentiation (Holt and Schuman, 2013; Martin and Ephrussi, 
2009). Recent in vitro studies revealed an unexpectedly large population of mRNAs in axons, 
and inhibiting the translation of just one or two of them can cause specific defects in 
fundamental axonal behaviors, such as neurotrophin-induced outgrowth, branching, cue-
induced chemotropic responses and injury-induced regeneration (references in (Jung et al., 
2012)). In vitro studies have also provided evidence that extrinsic signals, such as guidance 
cues and growth factors, selectively induce rapid axonal synthesis of distinct protein subsets 
(references in (Jung et al., 2012)). A rational interpretation of these results is that specific 
subsets of mRNAs are coordinately translated when required while most axonally localized 
mRNAs remain translationally repressed. Thus, to understand the function of axonal mRNA 
translation, it is important to carry out a comprehensive and unbiased global analysis of the 
mRNAs that are specifically translated in the axonal compartment in vivo.  
 
The axons of retinal ganglion cells (RGCs) terminate in the superior colliculus (SC) of the 
midbrain. A point-to-point topographic projection of RGC axons to the SC allows the brain to 
reconstruct a map of the outside world. In mouse, the formation of this retinotopic map in the 
SC can be divided into three distinct phases (Feldheim and O'Leary, 2010). First, embryonic 
RGC axons enter the SC and initially extend beyond their topographically correct 
“termination zones (TZs)” without branching or synapsing (elongation period). Second, 
interstitial branches arise from the primary axon shafts of RGCs in their appropriate TZs and 
begin to form synapses (branching/synaptogenesis period). Third, in the first two postnatal 
weeks, correctly wired axon branches are strengthened and excess inappropriate branches 
are pruned (pruning period) resulting in the mature topographic map in adulthood (Fig. 1A) 
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(Godement et al., 1984). Intriguingly, evidence suggests that local mRNA translation in the 
RGC axons may regulate subtle aspects of the formation of the retinotectal projection in vivo 
(Brunet et al., 2005). It is not known, however, which mRNAs are axonally translated and 
which specific aspects of visual circuit assembly they affect. 
 
To address this issue, we developed axon-TRAP (Translating Ribosome Affinity Purification) 
in mouse, a method that allows specific isolation of ribosome-bound mRNAs in the distal 
compartment of RGC axons in vivo. Analysis of these axon-specific translatomes at multiple 
ages reveals that axonal translation may play two major roles: regulation of protein and 
energy homeostasis, which is supported by mRNAs constitutively translated regardless of 
developmental stage; and regulation of stage-specific events, such as axon elongation, 
branching, pruning, synapse formation and synaptic transmission, which is supported by 
mRNAs whose translation is developmentally regulated. We also found that axonal mRNA 
translation continues in adulthood, when regulators of neurotransmission and axon survival 
are locally translated. Bioinformatic analysis of key translational regulators such as 
mammalian target of rapamycin complex 1 (mTORC1), fragile X mental retardation protein 
(FMRP) and adenomatous polyposis coli (APC), reveals that their target mRNAs are 
translationally co-regulated in a stage-specific manner. In addition, axonally translated 
mRNAs show extensive isoform diversity, yet only one single isoform is usually translated at 
any given time and these axonally translated isoforms share common regulatory sequence 
motifs that promote axonal mRNA translation. Collectively, the results provide direct 
evidence for the occurrence of developmental stage-specific, compartmentalized mRNA 
translation in developing and mature CNS axons and provide a deeper understanding of the 
molecular machinery involved in CNS wiring and maintenance.  
 
RESULTS 
1. Retinal RiboTag labels RGC axonal ribosomes in vivo 
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In order to isolate mRNAs translating in RGC axon terminals in the SC in vivo, we used the 
RiboTag knock-in mouse line (Sanz et al., 2009), in which Cre-mediated recombination 
switches the RiboTag allele, which encodes the 60S subunit protein ribosomal protein L22 
(rpL22), to the hemagglutinin (HA)-tagged rpL22 allele (HA-rpL22). We crossed this mouse 
with Pax6-alpha-Cre mouse (Marquardt et al., 2001), which transiently expresses Cre in the 
neural progenitors in the peripheral retinal primordium, permanently labeling RGCs (Fig. 1B, 
green area in the eye). We confirmed that no resident cells in the SC express Cre by two 
independent approaches, histological and molecular biological assay (Figs. 1CD & S1, see 
Extended Experimental Procedures). Therefore, the immunopurification of ribosome-mRNA 
complexes from the dissected SC allows us to profile local translation in axon terminals of 
RGCs in vivo (axon-TRAP) (Fig. 1B). 
 
We sought to visualize the labeled ribosomes using an HA antibody. HA-immunoreactivity 
was observed in the distal neural retina (Figs. 1E and S1) and the optic nerve head (ONH) 
(Fig. 1E, white box), the soma-free region where RGC axons collect to exit the eye, 
indicating that the RGC axons do contain HA-tagged ribosomes. To visualize the tagged 
ribosomes with higher resolution, we employed immuno-electron microscopy (EM). Immuno-
gold particles specifically labeled a subpopulation of ultrastructurally identifiable ribosomes 
(Fig. 1F) in the distal neural retina in a Cre-dependent manner (Fig. 1G). We successfully 
detected HA-tagged ribosomes in the axon shaft in the ONH and the optic nerve (ON) (Fig. 
1HI) and presynaptic terminals in the SC (Fig. 1J-L), indicating that HA-labeled endogenous 
ribosomes are transported to the axon. Together, our histological, molecular biological, and 
ultrastructural analyses indicate that Retinal RiboTag faithfully labels retinal axonal 
ribosomes in the SC. 
 
2. An unbiased identification of the axonal translatome 
Since the mRNA bound to the labeled axonal ribosomes of RGCs represents only a small 
fraction of the mRNA in the SC, a major caveat of axon-TRAP is non-specific binding of 
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mRNAs derived from the SC cells to immunoglobulins, Protein G and magnetic beads. To 
reduce this background noise, we first optimized the immunopurification protocol before 
performing axon-TRAP. We estimated that approximately 40% of HA-tagged translating 
ribosomes could be purified in this optimized protocol (Figs. 2A & S2AB, see Extended 
Experimental Procedures). Successful isolation of axonal ribosomes was confirmed by silver 
staining (Fig. S2B) followed by mass spectrometry (unpublished observation), although 
RpL22-HA pulled down from the SC was below the level of detection by Western blot. To 
assess the levels of background noise, we compared the levels of cDNAs amplified from 
TRAPed mRNAs (Fig. S2C) between the Cre-positive and -negative littermates. Although 
axon-TRAP was clearly dependent on Cre and therefore specific, additional amplification led 
to an increased background (Fig. 2B). We took advantage of this background “noise” 
reasoning that the Cre-negative samples would control for all the potential causes of false-
positive signals which any technical modification could not completely eliminate.  
 
In addition to avoiding any noise in the signal, we also wanted to assure ourselves that the 
signal came from mRNAs that were actively being translated, because 80S ribosomes can 
be stalled during translation by translational repressors such as FMRP (Darnell et al., 2011). 
In vitro ribosome run-off (see Extended Experimental Procedures) decreased the amount of 
TRAPed mRNAs to the degree that it could not be distinguished from the Cre-negative 
control (Fig. S2D), indicating that the majority of TRAPed mRNA comes from actively 
translating ribosomes. RNA sequencing analysis showed that we could detect 85% of 
TRAPed mRNAs isolated from adult axons as being actively translated (Figs. 2C & S2E). We 
use the term ‘translatome’ for ribosome-bound mRNAs in this study but it should be noted 
that approximately 15% of these may represent translation-stalled mRNAs. 
 
3. Axon-TRAP identifies changing population of ribosome-bound mRNAs in 
developing and mature axons in vivo 
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We used axon-TRAP on SCs dissected out at three specific stages during retinotectal 
development and in the adult: embryonic day 17.5 (E17.5) (elongating); postnatal day 0.5 
(P0.5) (branching); P7.5 (pruning); and adult (mature) (Fig. 1A). To compare the axonal 
translatome with the somal translatome, we also analyzed the ribosome-bound mRNAs in 
dissected Cre-positive retina, which contains the cell bodies of RGCs. When we plotted the 
normalized read count (fragments per kilobase of transcript per million mapped reads, 
FPKM) of each mRNA TRAPed from Cre-positive over Cre-negative SC samples, Cre-
dependent signals of mRNAs were immediately visible (Fig. 2D, left panel, black dots). This 
was in contrast with the plot with two biological replicates of Cre-negative SC samples, which 
showed a clear correlation (Fig. 2D, left panel, blue dots). To select Cre-dependent mRNAs 
in an unbiased way, we performed “differential expression analysis” on biological replicates 
of Cre-positive and -negative samples using NOIseq, which is well suited for quantitative 
comparisons for independently performed RNA-seq samples (Tarazona et al., 2011) (Figs. 
2D and S2F, see Extended Experimental Procedures). We defined these genes as 
“differentially expressed genes (DEGs)” (Figs. 2D & S2F, right panel, red dots) (Table S1) 
and used these for most of the downstream analyses.  
 
The total number of axonally translated mRNAs was higher in early stages, peaking at P0.5, 
and decreased postnatally whereas mRNAs that are translated within the retinal somas 
showed little change over the periods examined (Fig. 2E), consistent with the amounts of 
axon-TRAPed cDNAs (Fig. S2A). Although previous studies demonstrated that proteins are 
synthesized in developing axons, it has been controversial whether mature CNS axon 
terminals also have an ability to synthesize proteins at all, partly because of early studies 
detecting few or no ribosomes in mature axons (references in (Piper and Holt, 2004)). 
However, the presence of DEGs, approximately 85% of which were confirmed as being 
translated (Figs. 2C & S2E), and ribosomes (Fig. 1IL) in adult axons indicates that axonal 
mRNA translation persists in adult CNS axons. The axonal translatome of RGCs is largely an 
evolving subset of the significantly larger somal translatome (Fig. 2F), confirming that axon-
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TRAPed mRNAs originate from RGC neurons. Unlike the somal translatome (Fig. S3A), 
however, the axonal translatome showed extensive developmental regulation (see detailed 
analysis below) with only 694 out of 2576 (27%) mRNAs translating at all stages (Figs. 2G & 
S3A), indicating that the axonal translatome is not due to the simple passive diffusion of 
translating mRNAs from the soma. 
 
4. Axon-TRAPed mRNAs encode axon-specific proteome 
To discover which classes of mRNAs are preferentially translated in the axon, we performed 
a gene ontology (GO) enrichment/depletion analysis for genes whose translation level is 
significantly higher (>100-fold difference) in the axon than in the retina (Fig. 3A: “axon-
enriched mRNAs”). Reassuringly, analysis with the cellular component category showed that 
axon-enriched mRNAs generally encode proteins that are already known to function in 
axons, growth cones and synapses (Figs. 3B & S3B). In contrast, mRNAs encoding nuclear 
proteins (e.g. modifier of chromatin structures) are depleted from axonal translatome. GO 
terms selectively enriched in the axonal translatome included those involved in vesicle-
mediated transport and calcium-mediated signaling (Fig. S3C), suggesting that these 
processes, which play key roles in the distal axon, may be regulated by local mRNA 
translation. 
 
To explicitly compare axonal and somal translatomes, we used ClueGO software, which 
reports how many genes in each cluster are assigned with specific GO terms. We compared 
2576 axonally translating mRNAs (“axonal translatome”) with the same number of mRNAs 
that are most abundant in the somal translatome but absent in the axonal translatome 
(“retina-only” translatome). We found that synapse- and axon-related GO terms were 
generally associated with the axonal translatome, while the retina-only translatome was 
enriched with basal body and nuclear GO terms (Fig. 3C). These results indicate the 
presence of mechanisms for selecting specific mRNAs for axonal translation. 
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5. Axonal translatome changes from axon elongation to neurotransmission during 
development 
To correlate the local translation with the stage-specific events in axon development, we 
performed a GO-based analysis for genes that are translated in axons at each 
developmental stage using 455 neuron-related GO terms (Table S2). The translatome in 
younger axons (E17.5 and P0.5) was highly enriched with axon development-related GO 
terms, including “neuron projection morphogenesis”, whereas that of older axons (adult) was 
enriched with synaptic transmission-related GO terms, such as “synaptic transmission” (Figs. 
4A & S4A, & Table S3). The Ingenuity Pathway Analysis (IPA) for canonical signaling 
pathways also suggests that synapse function was most highly regulated in adult axons (Fig. 
S4B). This result suggests that axonal mRNA translation continues in the mature CNS of 
mammals in vivo and may regulate presynaptic function. We found that a number of genes, 
which are robustly translating in adult axons, encode glutamate receptors and neurotrophin 
receptors (Figs. 4B & S4C), some of which are known to regulate synaptic transmission in 
the pre-synaptic compartment (Pinheiro and Mulle, 2008). Furthermore, key components of 
the trans-SNARE complex, which mediates neurotransmitter exocytosis, are highly translated 
in mature axons (Fig. 4B), suggesting that their local translation plays a role in supporting the 
core machinery of neurotransmission in pre-synapses.  
 
Intriguingly, translation of receptors for axon guidance molecules peaks around birth (P0.5) 
and falls off thereafter (Figs. 4B & S4A). Because this is when interstitial branches arise from 
axon shafts in a topographically-biased manner to connect with targets (Fig. 1A), stage-
specific synthesis of these receptors in the RGC axon may help to fine-tune topographically-
biased branching. We also noted that the GO terms “neuron remodeling” and “collateral 
sprouting” were among most enriched in the pruning stage (P7.5). Genes with functions for 
synapse assembly, which include Neurexins and presynaptic cell adhesion molecules, were 
translating in all axons (Figs. 4B & S4A). 
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6. The axonal translatome changes from degenerative to survival modes at the end of 
development 
Axon survival is regulated through at least two pathways: by maintaining axonal 
protein/energy homeostasis and by inhibiting a destruction program mediated by Sarm1. 
Sarm1, which initiates a soma-independent axon destruction program by counteracting 
Nmnat function (Gerdts et al., 2015), is highly translated in developing but not in adult axons 
(Figs. 4B & S4C). The same pattern of local translation was observed for caspases, whose 
local action mediates axon dynamics and developmentally controlled branch destruction 
(Campbell and Holt, 2003; Campbell and Okamoto, 2013; Simon et al., 2012). These results 
suggest that developing (arborizing) axons synthesize the components of axon degeneration 
pathways, perhaps in highly restricted subcellular compartments within the axon, for the 
selective withdrawal of branches, whereas adult axons shut them off to maintain mature 
neural connections for long periods of time.  
 
GO terms related to mitochondrial and homeostatic functions, such as “cellular metabolism” 
and “mitochondrial respiratory chain”, were enriched at all stages, supporting the previous 
finding that axonal mRNA translation supports mitochondrial function and is required for axon 
survival (Figs. 4A and S4A) (Cosker et al., 2016; Hillefors et al., 2007; Yoon et al., 2012). 
The survival of a neuron whose axon reaches its correct target is regulated by retrograde 
transmission of a survival signal from the axon terminal, which turns on a transcriptional 
program for cell survival (Riccio et al., 1997). Previous studies showed that axonal synthesis 
of transcription factors, such as neurotrophin-induced synthesis of CREB (Cox et al., 2008) 
and SMAD1/5/8 (Ji and Jaffrey, 2012) and axon injury-induced synthesis STAT3 (Ben-
Yaakov et al., 2012), regulates cell survival during development and in adulthood. Indeed, 
our IPA analysis revealed that components of these nuclear signaling pathways including 
CREB and STAT3 signaling are enriched in adult axons (Fig. S4B). Therefore, our results 
suggest that local translation promotes survival of mature axons both by supporting 
mitochondrial function and actively generating survival signals. 
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Pathological axon degeneration in neurodegenerative diseases has been associated with 
impaired axonal translation (references in (Jung et al., 2012)). A KEGG pathway enrichment 
analysis showed a significant over-representation of genes linked to neurodegenerative 
diseases such as Alzheimer’s, Parkinson’s and Huntington’s diseases (Fig. 4A). In particular, 
we detected robust axonal translation of huntingtin (Htt), Prion protein (Prnp), microtubule-
associated tau (Mapt), and amyloid beta precursor protein (App), whose aggregates are 
strongly associated with neurodegenerative disorders (Fig. 4B), suggesting a possible 
connection of axonal translation to neurodegeneration involving protein aggregations. 
Intriguingly, activating transcription factor 4 (Atf4), whose excessive axonal translation 
spreads Alzheimer’s disease pathology across the brain (Baleriola et al., 2014), is also 
axonally translated at all stages tested. These results support the idea that dysregulated 
axonal translation may be an underlying cause of neurodegenerative diseases (Jung et al., 
2012). 
 
7. Targets of mTORC1, FMRP and APC show translational co-regulation in a stage-
specific manner 
We have shown that the axonal translatome is dynamically regulated during development, 
and this raises the important question of how axonal translation is controlled by upstream 
signaling pathways. To investigate this, we performed IPA upstream regulator analysis, 
which is based on published data of gene knockdown or knockout studies where protein 
products were measured when translational regulator function was impaired. mTORC1 
activity was predicted to peak in actively wiring axons as its target mRNAs showed a steep 
increase at P0.5 (Fig. S5A), consistent with previous studies demonstrating that axonal 
mRNA translation is regulated by mTORC1 (Campbell and Holt, 2001) and required for axon 
branching (Spillane et al., 2013). In contrast, the activity of FMRP was predicted to peak later 
at P7.5, because its target mRNAs (whose translation is repressed) showed a coordinate 
decrease in translation in mature axons (Figs. 5AB & S5AB). This result suggests that the 
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translational brake mediated by FMRP is utilized in maturing CNS axons as in dendrites 
(Bagni and Greenough, 2005; Darnell and Klann, 2013). Consistent with the result, known 
targets of FMRP and mTORC1 in the axonal translatome showed clearly different 
translational patterns from the non-target mRNAs: their translation increased at P0.5 (Fig. 
5A, left panel, red and blue: median shifts right) and decreased at P7.5 (right panel). Another 
intriguing translational regulator was APC, which was recently shown to regulate microtubule 
assembly and axonal growth by local translation (Preitner et al., 2014). Our analysis 
indicates that the translation of APC target mRNAs is highest in the youngest axons (E17.5) 
and steadily decreases thereafter (Fig. 5AB), consistent with the primary role of microtubule 
assembly in axon growth. In contrast, the targets of TDP-43 and FUS, well-known neuronal 
RNA-binding proteins (RBPs), showed a distribution not significantly different from the total 
axonal translatome (Figs. 5B & S5C), although the possibility remains that TDP-43 and FUS 
regulate stage-independent axonal mRNA translation. A principal component analysis (PCA) 
also showed a clear separation of the mTORC1, FMRP and APC targets from the rest of the 
axonal translatome (Fig. S5D). MicroRNAs (miRNAs) make up another class of translational 
regulators that function in the axon (Sasaki et al., 2014). We found that the translation of 
miR-1 target mRNAs decreases as the axon matures, suggesting that miR-1 abundance 
and/or activity increases during RGC axonal development (Fig. S5A).  
 
We took an independent approach to investigate the possibility of developmental stage-
dependent regulation of mTOR and FMRP signaling in RGC axons. We measured the 
abundance of phosphorylated mTOR (p-mTOR) and S6 (p-S6) in cultured primary mouse 
RGC axons by quantitative immunofluorescence (QIF), which positively correlate with 
mTORC1 activity (Copp et al., 2009; Laplante and Sabatini, 2012) (Fig. 5C). We found that 
they increased between E17.5 and P0.5, supporting our hypothesis that mTORC1 activity 
rises in RGC axons during this period. In contrast, the level of FMRP decreased in the same 
period, in accordance with our model that the translational brake is weakened in P0.5 axons 
(Fig. 5C). 
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To gain more insight into mRNA-specific translation in the axon, we compared the RGC axon 
transcriptome of E17.5 (Zivraj et al., 2010) to the axon translatome at the same stage. We 
analyzed the genes that are detected in the transcriptome but not in the translatome because 
this group may contain candidates for translationally repressed (‘masked’) mRNAs. We found 
that a significant portion of these candidates was translating at the three later stages tested 
(P0.5, P7.5 or adult) because their levels in the transcriptome correlated with the probability 
for translation at later stages (Fig. 5D). This suggests the possibility that the mRNAs, which 
are present in high abundance but not translating, are being stored for translation in later 
stages. In contrast, the genes that are present both in the young transcriptome and 
translatome did not show this trend (Fig. S5E). 
 
Strikingly, mRNAs that are ‘unmasked’ at the same stage encode various components of 
specific signaling pathways (Fig. 5D). For example, components of dopamine receptor 
signaling, Wnt/β-catenin signaling and the oleic acid biosynthesis pathway were specifically 
unmasked in P0.5, P7.5 and adult axons, respectively. Additionally, as noted above, mRNAs 
that are unmasked at the same stage share common translational regulators (Fig. 5D). 
Together, these results show that functionally coherent sets of mRNAs are coordinately 
translated in the axon by shared upstream regulators. 
  
8. Alternative splicing generates mRNA isoform diversity in the axon 
Post-transcriptional RNA processing events, including alternative splicing, are widely used to 
control gene expression in neurons. To assess whether these regulate local mRNA 
translation, we analyzed the mRNA isoforms on mapped sequence reads using MISO 
software (Katz et al., 2010). Intriguingly, the axonal translatome showed more extensive 
diversity of mRNA isoforms than the somal translatome (Fig. 6A). To address the possibility 
of isoform-specific axonal translation, we selected 164 alternative events that produce two 
isoforms both in the axonal and retinal translatomes. Then, we calculated the 'percentage 
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spliced in' (PSI or Ψ) values, which represent the fraction of the longer isoform (Katz et al., 
2010). Ψ retina was uniformly distributed (0< Ψ<1) indicating that there is no clear bias in 
translational efficacy (Fig. 6BC). However, Ψ axon was biased to the two extremes (i.e. Ψ=0 or 
Ψ=1), indicating that only one of the two isoforms is selectively translated in the axon (Fig. 
6BC).  Notable examples are acot7, an acyl-CoA thioesterase gene required for lipid 
biosynthesis and neuron survival (Ellis et al., 2013), syntaxin 3 (stx3), a SNARE component 
gene, and clta, a clathrin light chain A gene, which show clear axon-specific usage of first, 
last and internal exons, respectively (Figs. 6DE & S6A). Intriguingly, axon-specific isoforms 
of acot7 and stx3 encode proteins with slightly different amino acids at the N- and C-termini, 
respectively (see gene models in Fig. 6DE), suggesting that alternative splicing may couple 
axon-specific protein isoforms with a unique sequence tag in the UTR. 
 
Unexpectedly, we detected a number of back splicing events for three genes (Rhobtb3, Ubn2 
and Ankrd12), which indicate the potential presence of circRNAs in the axonal but not in the 
retinal translatome, and we could detect these mRNAs by RT-PCR of unamplified axonal 
translatome (Fig. S6B). Although previous studies suggested that the circRNAs are not 
translated (Guo et al., 2014), our result raises the possibility that the ribosomes can 
associate with circRNAs in axons. However, further studies are needed to address whether 
proteins are actually synthesized from these circRNAs.  
 
9. Cis-regulatory elements couple alternative splicing with axonal translation 
The dominance of a single alternative exon in axons suggests that axonal mRNA translation 
might be mechanistically linked to alternative splicing. We focused on the axonally enriched 
mRNAs with an alternative first or last exon because 5’- and 3’-UTRs generally contain 
localization signals (references in (Jung et al., 2012)) (Fig. 6DE). In order to investigate 
whether the axon-specific exons are sufficient to promote axonal mRNA transport and 
translation, we used a diffusion-limited, membrane-targeted EGFP (myr-d2EGFP), which is a 
faithful reporter of local protein synthesis in dendrites (Aakalu et al., 2001) and in axons 
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(Andreassi et al., 2010; Cox et al., 2008). We fused the axon-specific or axon-absent (retina-
restricted) alternative exon of each gene to myr-d2EGFP so that a reporter mRNA containing 
each motif would be generated in cells (Fig. 7AB). To test these reporters in retinal ganglion 
cells, the same cell-type from which they were identified, we used Xenopus primary retinal 
cultures (Campbell and Holt, 2001), which is amenable to screening multiple motifs. We 
confirmed that alternative usages of 5’- and 3’- UTRs of acot7 and stx3, respectively, are 
conserved between mouse and Xenopus (Xenbase and UCSC genome browser). 
Fluorescence recovery after photobleaching (FRAP) was monitored in the growth cones of 
cultured RGCs at 1 min intervals for 10 min. Remarkably, the axon-specific isoforms showed 
rapid and robust FRAP signal whereas the retina-specific isoforms did not (Fig. 7AB). These 
results indicate that axon-specific exons of acot7 and stx3 are sufficient to promote axonal 
mRNA translation (Fig. 7AB). 
 
We next investigated whether axon-specific exons might contain ‘generalizable’ motifs 
responsible for axonal mRNA translation. We searched for common sequence elements that 
are enriched in axon-specific alternatively exons (Fig. 7C) and in the 5’- and 3’-UTRs in 
constitutive exons (Fig. S7AB) of axon-enriched mRNAs (Fig. 3A). To understand the 
potential function of identified sequence elements, we searched for genes that contain these 
elements in the entire mouse genome. Remarkably, the element-containing genes generally 
encode regulators of axon and synapse function (Figs. 7C & S7C). Strikingly, five of six 
motifs identified from alternative exons and five of twelve motifs in constitutive exons of axon-
enriched mRNAs showed significant a FRAP signal at 10 min indicative of increased axonal 
mRNA translation of a reporter mRNA when incorporated in the 5’ or 3’-UTR as in Figure 7B 
(Figs. 7C & S7C). These results suggest the potential links between the sequence elements 
and axonal mRNA translation, and thus provide further insight into the mechanisms 
underlying the selective and dynamic nature of the axonal mRNA translation. 
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DISCUSSION  
Here, we developed a mouse model of axon-TRAP to isolate mRNAs translating in the distal 
axon of RGCs in vivo and performed a genome-wide survey of the axonal translatome at 
critical time points during the assembly of visual circuitry and in adulthood. The axonal 
translatome is generally a subpopulation of its somal counterpart but is enriched in genes 
with axon-specific roles. We found that broadly two classes of local translatomes exist in the 
distal axon, one being constitutively translated and the other being developmentally 
regulated. The former generally encodes the regulators of protein and energy homeostasis 
and the latter encodes proteins required for stage-specific events, such as axon elongation, 
axon branching, synapse formation and synaptic transmission. The adult axonal translatome 
is unique and its main role is likely to regulate synapse function. Developmentally regulated 
translatomes were subdivided according to the changes in translation between stages, and 
those that showed a coordinate change were found to share common upstream regulators, 
such as mTORC1, FMRP and APC as well as novel sequence elements that possibly 
regulate axonal mRNA translation. Additionally, we found that axonally translated mRNAs 
were frequently specific splice variants that carried axon-specific motifs. Together, our results 
show that extensive local mRNA translation occurs in the developing and mature mammalian 
CNS axons in vivo, and provide strong evidence that highly regulated axonal mRNA 
translation might be at the heart of CNS development and the maintenance of synaptic 
function.  
 
Previous studies using cultured neurons have revealed that some mRNAs are stored in a 
translationally repressed state (Buxbaum et al., 2014; Graber et al., 2013). Two independent 
and complementary approaches have been developed to ask which mRNAs are translating 
in the axon (Kim and Jung, 2015): metabolic labeling of newly synthesized proteins and 
isolation of ribosome-bound mRNAs. Proteomic approaches provide the ultimate readout of 
gene expression as they can identify post-translationally modified protein products, but a 
critical limitation of proteomics is that the probe – tagged amino acid or its analogs label all 
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cells, limiting its use to compartmentalized axon culture. An alternative strategy to identify 
newly synthesized proteins is to look at translating mRNAs (translatome), because these are 
the obligate precursor to the de novo proteome. A key advantage of this approach is that 
ribosomes can be isolated from a specific cell type, by expressing a genetically encoded 
epitope-tagged ribosomal protein in just the cells of interest (TRAP) (Heiman et al., 2008). 
Isolated ribosome-mRNA complexes either can be partially digested by RNase, and the 
fragments protected by ribosome binding can be sequenced (“Ribosome profiling”) (Ingolia et 
al., 2011), or the entire mRNA can be separated from the ribosome and directly sequenced. 
Only the latter method, which we use in this study, allows the discovery of novel isoforms 
outside the protein-coding region.  
 
We compared translatomes of RGC axons and retinal cell bodies in the same animals. It 
should be noted that the retinal translatome includes the translatome of the short axons and 
dendrites of the intraretinal circuitry, as well as their cell bodies. Therefore, the number of 
mRNAs that are identified as selectively translating in the axon in this study may be an 
underestimation. Additionally, the expression of tagged-ribosomes in non-RGC retinal 
neurons can potentially introduce bias into the axon/soma ratio. However, given the previous 
observations on retinal cell populations (Young, 1985), the presence of non-RGC mRNAs in 
the retinal sample cannot explain the axonal enrichment of mRNAs above the threshold 
(FPKMaxon / FPKMretina > 100), which we used for the axon-soma comparison. The strong 
enrichment of genes with axonal function in the axonal translatome compared to the retinal 
translatome suggests that these mRNAs were disproportionately represented in the axonal 
translatome, indicating that that axonal translation is mRNA-specific.  
 
In this study, we show that the RGC axonal translatome changes in a developmental stage-
specific manner, in such a way that proteins playing a key role at specific periods are 
synthesized when needed. This result is in agreement with a recent study using the 
Drosophila visual system, which reported that neuronal differentiation associated with 
18 
maturation of presynaptic terminals is regulated by coordinate control of mRNA translation 
(Zhang et al., 2016), although the subcellular location of mRNA translation was not 
addressed in that study. Whether signals that regulate mRNA-specific translation come from 
a cell-intrinsic timer or cell-extrinsic cues remains to be investigated, but our bioinformatic 
and experimental analyses suggest that this involves stage-dependent activation of RNA-
binding proteins, including FMRP. Because FMRP is known to inhibit translation of proteins 
required for synapse formation and its loss of function leads to over-branching of central 
nervous system axons (references in (Darnell and Richter, 2012)), it is reasonable to assume 
that FMRP may be activated after CNS axons make appropriate synapses to limit the 
number of synapses that a single axon makes. In this sense, it is intriguing that defective 
translational machinery, which is expected to affect all cells in the organism, leads to 
enigmatically synapse-specific phenotypes ranging from defective synaptic transmission to 
impaired cognitive function and memory (references in (Buffington et al., 2014)). Although 
the subcellular location of this pathogenesis is unknown, it will be interesting to test whether 
the axonal translatome of developing cortical neuronal axons in these mouse models of 
neurodevelopmental disorders is any different from normal mice.  
 
The local mRNA translation in axons of mature neurons has been a subject of long-standing 
debate (Piper and Holt, 2004). Evidence indicates that ribosomes exist in mature CNS axons 
(Koenig et al., 2000; Kun et al., 2007; Walker et al., 2012) and that their number is 
dynamically regulated under normal and pathological conditions (Verheijen et al., 2014). 
However, what proteins are locally translating in the mature axons was unknown. Our 
comparative analysis of mature and developing retinal axonal translatomes suggest that local 
protein synthesis regulates synaptic transmission and axon maintenance. Because axonal 
translation has been implicated in axonal survival and degeneration (Jung et al., 2012), it will 
be important to find out whether pathological axon degeneration is preceded by defective 
axonal translation. The power of axon-TRAP is that it can be extended to other neurons 
whose cell bodies and axons are anatomically separated. One such example is cortical and 
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spinal motor neurons, whose axonal degeneration leads to human diseases such as 
amyotrophic lateral sclerosis (ALS). Recent evidence suggests that defective axonal mRNA 
transport and translation may be an underlying cause of ALS pathology (Alami et al., 2014; 
Murakami et al., 2015). Our new technical approach and datasets should provide a valuable 
resource for future studies. 
 
 
EXPERIMENTAL PROCEDURES 
 
Histological analysis 
For immunohistochemistry, tissue sections (12 µm) were visualized using an anti-HA 
antibody (Abcam ab9110) and a secondary antibody conjugated to Alexa Fluor 488 (Life 
technologies). For immuno-gold electron microscopy, tissues were fixed in 4% 
paraformaldehyde in 0.1M HEPES (pH 7.4), and the HA-tagged ribosomes were visualized 
by the same anti-HA antibody and IgG conjugated with gold (10nm-15nm). Mouse RGC axon 
culture and quantitative immunofluorescence were performed as previously described (Zivraj 
et al., 2010) using the following antibodies: anti-mTOR (phospho S2448) antibody (Abcam 
109268), anti-FMRP antibody (Abcam 17722), and anti-RPS6 (phospho S235 + S236) 
antibody (Abcam 12864).   
 
Axon-Translating Ribosome Affinity Purification (TRAP) 
A homozygote RiboTag female mouse was mated with a Pax6-alpha-Cre male, to produce 
Cre-positive and Cre-negative mice in a single litter. Three eyes or six SCs were 
homogenized and post-mitochondrial fractions were collected. The mRNA-ribosome 
complexes were precipitated using the polyclonal HA antibody and Dynabeads Protein G 
(Life Technologies 10004D). For the in vitro ribosome run-off experiments, TRAP was 
performed after lysate was incubated with rabbit reticulocyte lysate (Promega), harringtonine 
(Sigma) and 4E1RCat (Sigma) at 37°C for 30 min. Ribosome-bound mRNAs were amplified 
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by a method developed by Tang and colleagues (Tang et al., 2009) with slight modification 
and sequenced using Illumina HiSeq2000 or NextSeq500. 
 
Data analysis 
The sequence reads were mapped using TopHat 2 version 2.0.12 and FPKM values were 
estimated using Cufflinks. Read counts for each gene were determined using HTSeq version 
0.6.1p1. For the identification of translated mRNAs in RGC axons, we applied the differential 
gene expression analysis on read count using NOISeq. De novo motif analysis was 
performed using HOMER version 3.0 with custom FASTA files. All RNA-seq data are 
deposited in Gene Expression Omnibus (GEO) datasets under accession number 
GSE79352. 
 
A detailed description of all experimental procedures is provided in the Supplemental 
Information. 
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FIGURE LEGENDS 
 
Figure 1. Retinal RiboTag labels RGC axonal ribosomes in vivo. (A) Development of 
retinal ganglion cell (RGC) axons in the superior colliculus (SC). (B) Strategy of axon-TRAP. 
(C) PCR that detects Cre transgene (upper) and rpL22 allele (lower). (D) PCR of genomic 
DNA from the retina and the SC that distinguish recombined and unrecombined RiboTag 
alleles. (E) HA fluorescence immunohistochemistry. (F-L) HA immunogold electron 
microscopy (EM). HA-tagged ribosomes localize to retinal cell bodies (F), and RGC axons 
(Ax) in the optic nerve head (ONH) (H), optic nerve (ON) (I) and RGC axon terminals in the 
SC (J-K). Two or more adjacent gold particles (purple arrows) were regarded as specific 
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signals. Scattered single immunogold particles may be nonspecific (yellow asterisks). 
Ultrastructure of polysomes is visible in the cell bodies in the retina and the SC (white 
arrows), but these co-localize with immunogold only in the retina (F). E: embryonic day; P: 
postnatal day; Nuc: nucleus. Scale bars: 500 µm (E) and 500 nm (F-L). 
 
Figure 2. Unbiased identification of the axonal translatome. (A) HA-labeled ribosomes 
were TRAPed by two independent antibodies against HA, and then co-immunoprecipitated 
ribosomal proteins from 60S (i.e. rpL24) and 40S (i.e. rpS3a) were visualized by Western 
blot. IgG LC, immunoglobulin G light chain. (B) Double strand cDNAs were made from 
TRAPed RNAs. (C) A scatterplot of log2 (FPKM) between Cre-positive/-negative (x axis) and 
Cre-negative axons (y axis). (D) Read counts of adult SC samples with or without ribosome 
run-off. Left panel is a scatter plot of log2 (read count+1) and right panel represents the 
percentage of genes whose read counts were decreased by run-off. (E) Change in numbers 
of DEGs in the retina and axon. For axon, dark pink indicates DEGs at the corresponding 
stages. Light pink indicates genes which are DEGs only at that stage. Combined value of 
orange and peach (union of DEGs) indicates the size of axonal translatome. (F) Somal 
versus axonal translatomes. (G) Four different axonal translatomes. 
 
Figure 3. Comparison between the axonal and retinal translatomes (A) Normalized 
mRNA levels (log2(FPKM)) between the axonal (y axis) and retinal (x axis) translatome at 
stage P0.5. Axon- and retina-enriched population were defined when FPKMaxon  / FPKMretina > 
100 and < 0.1, respectively. (B) GO terms in the cellular component category. More detailed 
lists are in Fig. S3B (grey, not detected). (C) ClueGO analysis. The left axis indicates the 
parental GO terms. The percentage of daughter GO terms associated with somal and axonal 
translatome is presented.  
 
Figure 4. Developmental changes of translated genes in RGC axons (A) Enriched GO 
(biological process) terms and KEGG pathways for axonally translated genes, sorted by 
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significance for each stage (Fisher’s exact test). The enrichment was analyzed by topGO 
(Table S3). Statistically significant cells are marked by black squares. (B) Normalized levels 
of axonal translation for selected genes (grey, not detected).  
 
Figure 5. Trans-acting elements that regulate the axonal translatome (A) Density plots 
of the change in FPKM values of axonal translatomes during two consecutive developmental 
stages (log2(stage A(FPKM) / stage B (FPKM)) (grey, distribution of all genes; colors, 
distribution of target genes) with p-values (Kolmogorov-Smirnov test). (B) Average log2 
(FPKM) values of target genes (mean±95% confidence interval). (C) Representative 
immunofluorescence images (left) and their quantification (right) (mean±SEM). ***p<0.001, 
Mann-Whitney test.  Scale bar, 10 µm. (D) Relationship between transcript abundance of the 
genes not detected in E17.5 axonal translatome (read count = 0) and probability of their 
translation at later stages (upper left: blue line, mRNA level in transcriptome; red line, moving 
averages of percentage of genes detected at any of three later stages over a window size of 
100 genes; r, Pearson correlation coefficient). The upper right and lower heatmaps show 
mRNA abundance in the translatome and enriched regulators/pathways, respectively. 
 
Figure 6. Alternative splicing generates high isoform diversity in axons. (A) Percentage 
of genes with alternative events from all axonally translated genes. Alternative events are 
classified into 5 different classes depicted in the left panel.  (B) Scatter and density plots for 
the distribution of Percentage Spliced In (Ψ) values between the retina (x-axis) and the axon 
(y-axis). (C) Model for biased distribution of Ψ values in the axon. The comparison of two 
isoforms suggests that one of two isoforms is predominant in the axon.  (D-E) The sequence 
reads on acot7 and stx3 loci visualized by Integrative Genomics Viewer (IGV). The 
histograms show the depth of the reads displayed at each locus. The retinal isoforms 
detected only in the retinal translatome, whereas the axonal isoforms are detected both in 
the axonal and retinal translatomes. 
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Figure 7. Cis-regulatory elements link alternative splicing to axonal translation.  
(A-B) Axon- and retina-specific acot7 and stx3 UTR isoforms fused with myr-d2EGFP were 
expressed in cultured RGCs (Xenopus). Quantification of fluorescence intensity after 
photobleaching (FRAP) revealed axon-specific isoforms of acot7 (A) and stx3 (B) markedly 
increase axonal translation of the myr-d2EGFP reporter construct compared to retina-specific 
UTR counterparts. Data at each 1 min timepoint represent mean fraction of recovery relative 
to pre- and post-bleach levels ±SEM. (n= 9 and 10 for axon and eye-specific 5’UTR of acot7, 
respectively; n = 14 and 14 for axon and eye-specific 3’UTR of stx3, respectively).  
***p<0.0001, two-way ANOVA. FRAP signal recovery was abolished by 40µM anisomycin 
(10 min post-photobleach: acot7 axon-isoform + anisomycin 0.064 ± 0.028; Stx3 axon-
isoform + anisomycin 0.085 ± 0.026). Representative images of RGC axonal growth cones 
showing fluorescent recovery after photobleaching for each reporter construct are shown 
(right). Scale bars, 10 µm. (C) GO enrichment analysis for entire genome containing axon-
specific sequence motifs associated with alternative exons (S: G or C) and their relative 
efficiency in axonal mRNA translation using myr-d2EGFP reporter constructs. Significance of 
FRAP recovery curves were compared to no UTR control across 10 min (n ≥ 10 for each 
construct). Statistical significance of FRAP compared to the no-UTR control was tested 
across all time-points (1-10 min) using a two-way ANOVA (*** p<0.0001 compared to no-
UTR control). For representative purposes, the mean fluorescence recovery at 10 min post-
photobleaching is shown. Error bars represent SEM. 
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EXTENDED EXPERIMENTAL PROCEDURES 
 
Animals 
RiboTag and Pax6-alpha-Cre mice were kind gifts from Dr Paul Amieux (University of 
Washington) and Dr Peter Gruss (Max Planck Institute), respectively. A homozygote 
RiboTag female mouse was mated with a Pax6-alpha-Cre male, to produce Cre-
positive and Cre-negative mice in a single litter. Cre-negative embryos or pups were 
used as negative controls for TRAP. Rosa26-StopLox-LacZ and Rosa26-StopLox-
TauLacZ were kindly provided by Dr Jin-Woong Bok (Yonsei University) and Dr 
Soochul Park (Sookmyung Woman’s University), respectively. All procedures were 
conducted under license in accordance with UK Home office guidelines and under 
the Guidelines for the Care and Use of Laboratory Animals of Yonsei University 
College of Medicine. 
 
Monitoring of Cre-recombinase activity in Pax6-alpha-Cre mice 
As even slightly leaky expression of the HA-tagged ribosome in any SC-resident cells 
would lead to misidentification of axonally translating mRNAs, we needed to confirm 
that no resident cells in the SC express Cre. We took two independent approaches. 
In the first, we used two Cre-responsive reporter mice: one that labels the cell bodies 
of Cre-expressing cells and their progeny (Rosa26-StopLox-LacZ) and the other that 
labels the axons of these cells (Rosa26-StopLox-TauLacZ). In accordance with the 
previous reports (Marquardt et al., 2001), LacZ-positive cell bodies were only 
observed in the neural retina but not in the SC (Fig. S1). Using the StopLox-TauLacZ 
reporter mouse to visualize retinal axons, we could see the SC is richly innervated by 
the axons originating from their Cre-positive cell bodies in the retina (Fig. S1). In the 
second approach, we crossed this mouse with RiboTag (Fig. 1C), and asked whether 
we could detect any trace of the recombined RiboTag allele (HA-rpL22) in the SC. If 
the SC contains any resident cells that have expressed Cre but escaped our 
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histological analysis, the nuclear DNA extracted from this tissue must contain the 
HA-rpL22 allele, which we can detect using PCR-based assays (Fig. 1D). We 
detected no such signal in the SC dissected for TRAP (Figs. 1D and S1, red box). 
Therefore, both histological and molecular biological assays confirm that the only 
source of HA-tagged ribosomes in the SC is the RGC axons. Genotyping was 
performed by polymerase chain reaction (PCR) using the following primer pairs: for 
the Cre transgene, forward 5’- GCATTACCGGTCGATGCA ACGAGTG-3’, and 
reverse 5’- GAACGCTAGAGCCTGTTTTGCACGTTC-3’; for the RiboTag allele, 
forward 5’-GGGAGGCTTGCTGGATATG-3, and reverse 5’- TTTCCAGACACAG-
GCTAAGTACAC-3’; for detection of the recombined RiboTag allele (HA-rpL22), 
forward 5’-TTCTCTAGAAAGTATAGGAACTT-3’, and reverse 5’-ACATCGTATGGG-
TATAGATCC-3’. Cre-negative embryos or pups were used as negative controls for 
TRAP.  
 
Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) 
cDNA was synthesized using an oligo-dT primer and SuperScript III reverse 
transcriptase (Invitrogen). The qPCR was performed using QuantiTect SYBR Green 
PCR Kit (Qiagen) on Light Cycler LC480 II (Roche). The levels were normalized by 
the total RNA amounts. The following primer pairs were used: for Glud1, forward 5’-
GGGAGGTCATCGAAGGCTAC-3’, and reverse 5’-AGCCAGTGCTTTTACTTCAT-
CC-3’; for Mapt, forward 5’-TTCTGTCCTCGCCTTCT-GTC-3’, and reverse 5’-
CCTTCTTGGTCTTGGAGCAG-3’; for Rps5, forward 5’-TCAAGCTCTTTGGGAAAT-
GG-3’, and reverse 5’-GGGCAGGTACTTGGCATACT-3’; for Tsc2, forward 5’-
TAGGGCTCCTGGTCATCCTT-3’, and reverse 5’-GTGCT-TGTAATGGAGCTGGA-
3’; for Cfl1, forward 5’-TCTGTCTCCCTTTCGTTTCC-3’, and reverse 5’-
GCCTTCTTGCGTTTCTTCAC - 3’, for Aldoa, forward 5’-TTAGTCCTTTCGCCTA-
CCCA-3’, and reverse 5’-AGCTCCTTCTTCTGCTCCG-3’; for Atp5b, forward 5’-
CACAATGCAGGAAAGGATCA-3’, and reverse 5’-GGGTCAGTCAGG-TCATCAGC-
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3’; for Basp, forward 5’-ACAAAGACAAGAAGGCCGAA-3’, and reverse 5’-
CTCTCCTTGACCTCGGTGG-3’; and for Cend1, forward 5’-CCTGAGCACT-
CCTCGGTATC-3’, and reverse 5’-AGACCACAGTGGCTCAGGAC-3’. 
 
Histological analysis 
Mouse embryos were fixed by immersion in 4% paraformaldehyde in PBS.  Adult 
mice were transcardially perfused with the same fixative, and entire eyes and brains 
were dissected out and post-fixed. For X-gal staining, brains and retinae were 
dissected out, washed in ice-cold PBS and fixed for 1 hour in 1% formaldehyde, 
0.2% glutaraldehyde, 2mM MgCl2, 5mM EGTA, 0.02% NP-40 in PBS [pH7.5]) at 4°C 
on a shaker.  The dissected tissues were rinsed three times for 20 min each in PBS 
and stained with X-gal staining solution (1mg/ml X-gal diluted in DMF, 0.01% Sodium 
deoxycholate, 0.02% NP-40, 5 mM potassium ferricyanide, 2 mM MgCl2 in PBS) 
between 3 to 48 hours at 37°C in the dark. After washing with PBS, the tissues were 
post-fixed in 4% paraformaldehyde in PBS for 30 min at 4°C.  For 
immunohistochemistry, tissues were saturated in 30% sucrose, embedded in OCT, 
frozen on dry ice, sectioned at 12 µm by using a cryostat (Leica CM3050S), and then 
visualized using an anti-HA antibody (Abcam ab9110) and a secondary antibody 
conjugated to Alexa Fluor 488 (Life technologies). For immuno-gold electron 
microscopy, tissues were fixed in 4% paraformaldehyde in 0.1M HEPES (pH 7.4), 
and the HA-tagged ribosomes were visualized by the same anti-HA antibody and IgG 
conjugated with gold (10nm-15nm) at the Cambridge Advanced Imaging Centre 
(University of Cambridge, UK). Specific labeling was evident as ultrastructurally 
identifiable ribosomes were labeled by multiple gold particles (Fig. 1F, purple 
arrows). We did, however, occasionally observe scattered gold particles in the Cre-
negative tissue (Fig. 1G, white arrow), but these were never clustered as seen in the 
Cre-positive group. Therefore, we considered only two or more gold particles in close 
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proximity (within 50 nm between particles) as specific labeling of HA-positive 
ribosomes.   
 
Axon-Translating Ribosome Affinity Purification (TRAP) 
Tissue samples were dissected and snap-frozen in liquid nitrogen and genotyped.  
Whole eyes were used as the cell body group and the superior colliculus, where 
retinal axons terminate, were used as the axon terminal group.  Tissues from cre-
positive and negative were pooled for TRAP (three eyes and superior colliculi for one 
group).  Tissues were homogenized in lysis buffer (20mM HEPES-KOH, 5mM MgCl2, 
150mM KCl, 1mM DTT, SUPERase In, and Complete EDTA-free Protease Inhibitor 
Cocktail) in the presence of cycloheximide (to stop translational elongation and to 
lock translating ribosomes on the mRNA) and rapamycin (to prevent new 
translational initiation during immunoprecipitation), and post-mitochondrial fractions 
were collected. We optimized the TRAP protocol before performing axon-TRAP.  
First, we found the polyclonal HA antibody (9110, Abcam) is superior to the one used 
in the original RiboTag study (HA11, Covance) (Sanz et al., 2009). Although the two 
antibodies were similarly effective in precipitating HA-rpL22, the polyclonal antibody 
(Abcam ab9110) co-purified much more 80S ribosomes (Fig. 2A).  We estimated that 
approximately 40% of HA-tagged translating ribosomes could be purified this way, as 
the amount of TRAPed 80S ribosomes (i.e. co-immunoprecipitated rpS3a, a 40S 
ribosomal protein) was approximately 10% of the input (i.e. rpS3a in total input) (Fig. 
2A).  This estimation is based on the findings that (1) roughly 50% of retinal cells 
express HA-tagged rpL22 (i.e. 50% cells do not express tagged ribosomes), and that 
(2) these cells express rpL22 from one wildtype allele and one recombined HA-rpL22 
allele (i.e. 50% of rpL22 is labeled with HA in Cre-positive cells) ([total 80S] = [HA-
80S] x (1/50%) x (1/50%) = [TRAPed HA-80S] x (1/10%).  Therefore, [TRAPed HA-
80S] = (4/10) x [HA-80S]) (Fig. 2A). We found that the indirect immunoprecipitation 
protocol, which allows the antibody to bind the antigen before the purification of the 
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antigen-antibody complexes, was more specific than the direct protocol, which 
utilizes the antibody pre-conjugated to Protein G-magnetic beads.  We think that 
nonspecific binding of mRNAs to Protein G-magnetic beads was reduced in the 
indirect protocol, as the tissue lysate was pre-cleared with unconjugated Protein G-
magnetic beads.  Pre-cleared ribosome-mRNA complexes were immunoprecipitated 
by an anti-HA antibody and Dynabeads Protein G (Life Technologies 10004D).  Total 
RNA was extracted from the ribosome-mRNA complexes using an RNeasy mini kit 
(Qiagen) followed by in-column DNase treatment to remove genomic DNA 
contamination.  The RNA samples were examined for quantity and quality using the 
Agilent Bioanalyzer 2100 (Agilent Technologies). 
 
Amplification of cDNAs 
The amount of axon-TRAPed mRNA was minute and had to be amplified (Fig. S2A).  
We used a method developed by Tang and colleagues for single cell transcriptomics 
(Tang et al., 2009) with slight modification (Fig. S2A). First, TRAPed RNAs were 
treated with DNase I to eliminate genomic DNA contamination and then mRNAs 
were reverse-transcribed with oligo(dT) primer with a linker. After second strand 
synthesis with another linker, the double-strand cDNAs were amplified by ten rounds 
of PCR and visualized by agarose gel electrophoresis (Fig. 2B). The specificity of 
TRAP was evident because it was dependent on Cre. As expected, the amount of 
TRAPed mRNAs was lower in the SC (mRNAs from RGC axons) than in the eye 
(mRNAs from the cell body and proximal neurites), and therefore was further 
amplified by five additional rounds of PCR. Although axon-TRAP was clearly 
dependent on Cre and therefore specific, increasing PCR cycles led to an increased 
background (i.e. amplified cDNAs from the Cre-negative SC). We reasoned that the 
amplified DNAs in the Cre-negative SC would reflect the relative abundance of 
mRNAs in the SC.  We sequenced these mRNAs and used the data as a negative 
control for bioinformatics analysis of axon-TRAPed mRNAs (Fig. 2B). Amplified 
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cDNAs were subjected to paired-end 100 or 90 bp sequencing on the Illumina 
HiSeq2000. 
 
For the in vitro ribosome run-off experiment, eyes or superior colliculi were 
homogenized by the 400 µl lysis buffer without cycloheximide, and then 200 µl of 
rabbit reticulocyte lysate (Promega) and 8 µl of Harringtonine (100 ug /ml) and 4 µl of 
4E1RCat (5 mM) were added to the 188 µl lysate, followed by 37 °C incubation for 30 
min. To stop the in vitro translation elongation, 800 µl of ice-cold lysis buffer with 
cycloheximide was added, followed by immunoprecipitation with the anti-HA 
antibody. The purified RNAs were subjected to RNA sequencing on the Illumina 
NextSeq 500. To reflect the difference in amount of amplified cDNAs between the 
samples with and without run-off translation on the sequencing depth, we first 
measured the amount of cDNA by both Tapestation DNA and by Qubit. We then 
adjusted the ratio between the amounts of input libraries for multiplex sequencing 
using the ratio of cDNA amount between the two samples. All RNA-seq data are 
deposited in Gene Expression Omnibus (GEO) datasets under accession number 
GSE79352.  
 
Mapping of sequence reads and normalization of read counts  
The sequence reads were mapped to the mouse genome (mm10) using TopHat 2 
version 2.0.12 (Kim et al., 2013) with default settings, except for the "--read- realign-
edit-dist 0" option. This option was chosen to reduce mapping to pseudogenes. 
Although we detected a significant number of sequencing reads of the primer dimers 
in several samples, which are probably caused by the matching problem between 
our primers and Illumina primers, because there is no biological reason that these 
dimers bias the relative abundance of sequence reads of endogenous mRNAs, we 
analyzed all sequence reads that can be mapped to the mouse genome sequence by 
TopHat 2. Transcript assembly and estimation of FPKM (Fragments Per Kilobase of 
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transcript per Million fragments sequenced) values were performed using Cufflinks 
version 2.2.1 (Trapnell et al., 2010). Read counts for each gene were determined 
using HTSeq version 0.6.1p1 (http://www- huber.embl.de/users/anders/HTSeq/). For 
the analysis of run-off samples, we used the read counts for all DEGs (adult) 
detected either in the run-off positive or negative sample.  
 
Differential gene expression analysis and Gene Ontology based enrichment 
analysis 
For the identification of translated mRNAs in RGC axons, we applied the differential 
gene expression analysis on read count data between two biological replicates of 
Cre-positive and Cre-negative samples using NOISeq (Tarazona et al., 2011) in 
default conditions with probability threshold 0.7. Although this approach has a risk of 
filtering out actively translating mRNAs if the same mRNAs exist in high abundance 
in SC-resident cells and are proportionately represented in the negative control, we 
thought that it would be appropriate to take a conservative approach when analyzing 
mRNAs identified by highly sensitive RNA-seq from samples with potentially low 
signal-to-noise ratio.  DEG analysis identified a subset of Cre-dependent mRNAs 
(Fig. 2D, right panel, red dots) (Table S1).  In some cases, genes that passed our 
filtering criteria and were identified as DEGs in one stage failed the same test in 
other stages (Fig. 2D, orange), because their abundance in the negative control 
varied depending on the stage. Most of these mRNAs, however, were found in the 
axon-TRAPed mRNAs at all stages tested, suggesting that these genes became 
false negatives in other stages. Therefore, when we analyzed the developmental 
change in translation levels, we used the FPKM (fragments per kilobase of transcript 
per million mapped reads) values of all four stages for genes that have passed the 
DEG test in at least one stage (Union of DEGs) (Fig. 2D, orange and peach).   
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To perform a GO-based analysis for neuronal functions (Figs. 4A and S4A), we 
selected 455 neuron-related GO terms (Table S2) using the following criteria: all 
offspring GO terms (249 terms) of ‘Neuron development (GO:0048666)’, which 
contain GO terms related to neuron/axon development, and all offspring GO terms 
(206 terms) of "Synaptic transmission (GO:0007268)", which contain GO terms 
related to neurotransmission. The offspring GO terms were identified using the 
GOBPOFFSPRING function of GO.db, an R package (Table S2). The enrichment 
analysis for gene ontology was carried out with DAVID and topGO version 2.18. 
(Alexa et al., 2006) on R version 3.1.2. The result for all analyzed GO terms 
(biological process) is represented in Table S3. For Kyoto Encyclopedia of Genes 
and Genomes (KEGG) analysis, we used all 2576 axonally translated genes and 
calculated p values and fold enrichments using DAVID (Fig. 4A, lower panel). The 
numbers of GO terms associated with retinal and axonal translatome were analysed 
using ClueGO (Bindea et al., 2009). Statistically significant enrichment is annotated 
by a solid box outline. 
 
Ingenuity Pathway Analysis  
Ingenuity Pathway Analysis (Qiagen) for canonical pathways (Fig. 5A) was 
performed according to the manufacturer’s instructions. For quantitative analysis of 
stage-dependent axonal translation of each mRNA, we calculated the ratio in read 
counts of each mRNA from one stage to the next.  Then we performed Ingenuity 
Pathway Analysis (IPA) for upstream regulators, which mainly utilizes published 
results of gene knockdown or knockout studies. For example, if the protein product of 
a gene decreases when a specific translational regulator is knocked out, the gene 
would be described as “positively regulated” by the translational regulator (and vice 
versa) (Fig. 5B). 
 
Analysis of target mRNAs in the mTOR pathway and RNA binding proteins 
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We analyzed the known binding targets of RBPs using the results of previous studies 
on FMRP, TDP-43, FUS and APC. In addition, we carried out the same analysis on 
the targets of mTORC1 to confirm the result of IPA analysis. If any of these 
molecules regulate stage-specific translation in the axon, their target mRNAs would 
show coordinate changes in translation. We used the gene sets that were identified 
in previous studies (Colombrita et al., 2012; Darnell et al., 2011; Preitner et al., 2014; 
Thoreen et al., 2012). We analyzed mTOR targets that are described in the previous 
report (Thoreen et al., 2012) with a threshold of log2 (Torin1/Vehicle) < -1, FMRP 
targets (Darnell et al., 2011) with a threshold of rank (based upon chi-square score) < 
100 and all of the APC targets (Preitner et al., 2014), TDP-43 targets and FUS 
targets identified(Colombrita et al., 2012). In the FPKM ratio analysis for consecutive 
developmental stages, we used all genes that were detected in RNA-seq in order to 
avoid any bias caused by differential gene expression analysis.  Principle component 
analysis (PCA) was performed on normalized read counts of all samples to compare 
gene expression in 12 different conditions by using the “prcomp” function in the R 
Software package (version 2.13.0). Data were plotted using the first two PCs which 
explained up to 73.2% of the total variance: 66.1% explained by PC1; and 7.1% by 
PC2.  
 
Analysis of mRNA isoforms 
Alternative isoforms were analyzed on mapped reads from the P0.5 sample using 
MISO. Before this analysis, the mean and the standard deviation of the insert length 
and the total number of mapped read pairs were computed using the “pe_utils” 
utilities (Retina: mean=177.8, sdev=9.7, dispersion=0.7, num_pairs=3262858, Axon: 
mean=178.3, sdev=13.5, dispersion=1.0, num_pairs=2535309, Cre_negative axon: 
mean=179.6, sdev=9.2, dispersion=0.7, num_pairs=3235484). We used Mouse 
genome (mm10) alternative events version 1.0 (Wang et al., 2008) to perform “exon-
centric” analyses. We counted and analyzed only the events in which both splicing 
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variants are detected both in axon and in cell body (the events of “0 < Ψ <1" both in 
axon and in cell body). For the discovery of novel splice variants, we performed 
reference-independent transcript reconstruction using Cufflinks version 2.2.1 
(Trapnell et al., 2010) and compared the sequences of reconstructed transcripts with 
the UCSC Genes transcript annotations by using the Cuffcompare program from the 
Cufflinks package. For the identification of circular RNAs, we first extracted the fusion 
transcripts from the unmapped sequence reads by using TopHat-fusion (Kim and 
Salzberg, 2011) (TopHat 2.0.12, parameters:--fusion-search --keep-fasta-order --
bowtie1 --no-coverage-search), and then identified junction reads from back spliced 
exons using CIRCexplorer-1.1.1(Zhang et al., 2014). Mapped sequence reads are 
visualized using the Integrative Genomics Viewer (IGV) version 2.3.46 (Robinson et 
al., 2011). 
 
Identification of regulatory motifs in RNA 
De novo motif analysis was performed using HOMER version 3.0 (Heinz et al., 2010) 
with custom FASTA files. For the finding of motifs in UTRs, we used the UTR 
sequences of genes whose levels were higher in the axon than in the retina (axon / 
retina > 100, Fig. 3A) in P0.5 translatomes. For finding of motifs in axon-enriched 
alternative exons, detection of differential exon usage was performed using DEXseq 
version 1.10.8 (Anders et al., 2012) on R version 3.1.0, and exons were selected with 
a Benjamini–Hochberg adjusted p-value cut-off of < 0.1 (Benjamini and Hochberg, 
1995). To validate these motifs, we extracted the genes that contain these motifs 
allowing 0-1 mismatch and then compared the translation levels between axon and 
retina. Sequences of UTRs were retrieved from Ensemble BioMart (Kinsella et al., 
2011). Motif containing genes were identified using the Biostrings package on R 
version 3.1.2. 
 
Immunofluorescence 
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Mouse RGC axons were cultured as previously described (Zivraj et al., 2010). The 
cultures were fixed in 2% (vol/vol) paraformaldehyde/7.5% (wt/vol) sucrose, 
permeabilized with 0.1% Saponin (Sigma) and blocked in 5% goat serum, then 
labeled with primary antibodies overnight and Alexa Fluor 488 secondary antibodies 
(1:1000, Life Technologies), and mounted in FluorSave (Calbiochem). Randomly 
selected isolated axons were imaged with a Plan Apo 60X oil objective on a Nikon 
Eclipse TE2000-U inverted fluorescent microscope with a Hamamatsu ORCA-ER 
CCD camera. Exposure time was kept constant and below greyscale pixel saturation. 
For quantitation of fluorescence intensity, the outline of the axon segments with 
similar lengths was traced on the phase image using Volocity software 
(PerkinElmer), and then superimposed on the fluorescent image. The software 
calculated the fluorescent intensity within the axon segment, giving a measurement 
of pixel intensity per unit area. The axon outline was then placed in an adjacent area 
clear of cellular material to record the background fluorescent intensity. This reading 
was subtracted from the axon reading, yielding the background-corrected intensity. 
Each reading was normalized to the mean fluorescent intensity of E17.5 axons in the 
same group. The fluorescent intensities of between 50 to 100 axon segments per 
sample group were collected. The following antibodies were used: anti-mTOR 
(phospho S2448) antibody (Abcam 109268), anti-FMRP antibody (Abcam 17722), 
and anti-RPS6 (phospho S235 + S236) antibody (Abcam 12864).   
 
Fluorescence recovery after photobleaching (FRAP) 
Motif sequences were cloned into a plasmid containing the coding sequence of 
membrane-targeted, destabilized EGFP (myr-d2EGFP) (Aakalu et al., 2001) between 
NotI-Xhoi sites (for 3’-UTR and alternative exon) or NheI-BamHI sites (for 5’-UTR).  
Motif sequences are in Table S3.  The reporter plasmids were expressed in the 
retina by targeted electroporation into Xenopus laevis embryos, and fluorescence 
was imaged in cultured retinal ganglion cell axons as previously described (Leung et 
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al., 2006), except that 1% fetal bovine serum was added to the medium. In 
experiments to confirm translation-dependency of FRAP, the translation inhibitor 
anisomycin (40 µM) was added 30 min prior to imaging. FRAP experiments were 
performed on an Olympus IX81 inverted microscope equipped with a PerkinElmer 
Spinning Disk UltraVIEW VoX and a 60x (NA, 1.30) Olympus silicone oil immersion 
objective. Images were acquired with an ORCA-Flash4.0 V2 CMOS camera 
(Hamamatsu) using Volocity software (PerkinElmer). 
 
Photobleaching was performed using an UltraVIEW PhotoKinesis device 
(PerkinElmer). Regions of interest were manually defined so that growth cones and 
>20µm of the axon shaft were bleached (thus reducing likelihood of fluorescence 
recovery resulting from myr-d2EGFP diffusion from unbleached areas of the axon 
shaft). Photobleaching was performed at 50-85% laser power (488 nm laser line) 
with 20–30 bleach cycles.  Time-lapse images were captured at 1 min intervals using 
a 488 nm laser line at 25% laser power for myr-d2EGFP and a 561 nm laser line (31 
% laser power) for visualization of axons using a membrane-targeted mCherry-CAAX 
reporter, in addition to phase contrast. Exposure time for the 488 channel was 
adjusted to avoid pixel saturation and was typically between 50-200ms. 
Quantification of fluorescence intensity was performed using Volocity software 
(PerkinElmer). At each time point, the outline of the growth cone (ROI) was traced 
using the mCherry-CAAX reporter (561 channel) and phase contrast images. Mean 
gray values from the 488 channel were subsequently calculated as mean pixel 
intensity per unit area within the ROI. Subtracting the mean background pixel 
intensity per unit area from an equivalently sized ROI immediately adjacent to the 
growth cone normalised intensity values in the growth cone. Unhealthy axons 
exhibiting signs of photo-toxicity after FRAP (characterised by blebbing, growth cone 
collapse and/or retraction) were excluded from analysis. In addition, we only 
quantified growth cones of axons extending more than 100 µm from the eye explant 
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to reduce effects of somal diffusion. Relative fluorescent recovery (R) at each time 
point was calculated by the formula: Rx = (Ix – Ipost) / (Ipre – I post). Where, Ix = 
normalised fluorescent intensity of the growth cone ROI at time point ‘x’, Ipre = 
normalised fluorescent intensity before photobleaching and Ipost = normalised 
fluorescent intensity immediately after photobleaching (t=0 mins). 
Data were analysed using PRISM software (Graphpad). Significance was tested 
using a two-way ANOVA. 
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LEGENDS FOR SUPPLEMENTAL FIGURES AND TABLES 
 
Figure S1.  Specific labeling of retinal axons in Retinal RiboTag, Related to 
Figure 1 (A) Two Cre activity reporter mice were used in this study.  The LacZ 
reporter labels the cell bodies of Cre-positive cells and their progeny, whereas the 
TauLacZ reporter labels both the cell bodies and axons.  (B) X-gal staining of the 
retina, optic chiasm (OC) and superior colliculus (SC) in alpha-Cre; LacZ reporter 
gene double positive mice.  Cre labels most peripheral neural retinal cells in both 
mice.  No cells in the SC used for TRAP in this study express Cre as evidenced by 
the lack of X-gal stain in the LacZ reporter SC.  Unlike the alpha-Cre; LacZ mice, 
alpha-Cre; TauLacZ mice show robust staining not only in the cell bodies but also the 
OC and the SC. The SC, which was used for axon-TRAP, is highly innervated by 
retinal axons.  
 
Figure S2. Axon-TRAP, Related to Figure 2  (A) Bioanalyzer analysis of axon-
TRAPed mRNA.  Lower tables show the amounts of total RNAs and amplified cDNAs 
for each TRAPed sample. (B) Silver staining of axon-TRAPed protein complexes 
following SDS-PAGE. (C) Strategy for cDNA synthesis and amplification adopted 
from the study from Tang et al.  (D) Ribosome run-off experiment.   The amplified 
cDNAs from TRAPed mRNAs with or without run-off (P0.5 retina). (E) Retinal and 
axon-TRAP combined with ribosome run-off. (F) Scatterplots of log2 (FPKM) between 
Cre-positive (x axis) and Cre-negative axons (y axis).  
 
Figure S3. Comparison between the axonal and the retinal translatome, Related 
to Figure 3  (A) The upper panel shows a heat map of hierarchical clustering on the 
normalized level of axonal and retinal translation of genes. Each row in the heat map 
corresponds to a single gene. The color of the heat map represents the log2 (FPKM 
value) for each gene (grey = not detected). The lower panel shows a heat map of a 
6uSSOePeQWDO Iigure OegeQGV DQG ([FeO WDEOe OegeQGV 
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correlation matrix.  (B) Tables showing the ranking of most significantly enriched GO 
terms in axon-enriched mRNAs and retina-enriched mRNAs. Terms presented in 
Figure 3B are shown in red. (C) A heat map showing the enrichment of GO terms in 
the biological process (BP) category. The colors of the heat map represents the log2 
value of the fold enrichment for each GO term value (red = enriched, blue = depleted, 
grey = not detected), and the numbers on the heat map are –log 10 (Fisher's exact p-
value) for enrichment. 
  
Figure S4. Gene set enrichment analysis describing the developmental 
changes of translated genes in RGC axons, Related to Figure 4 (A) The upper 
heat map displays the enrichment of GO terms or KEGG pathways for axonally 
translated genes. Each row in the heat map corresponds to a single GO term. Genes 
are clustered either by stage-specific expression (“stages”) or hierarchical clustering 
(lower heat map) according to their developmental changes (“changes”).   (B) 
Ingenuity pathway analysis (IPA) to identify canonical pathways associated with the 
axonal translatome. Each row represents a single pathway (blue, enriched). The right 
panel shows lists of pathways extracted from each cluster. C) A heatmap showing 
the log2 (read count) for adult samples with and without ribosome run-off. Each row in 
the heat map corresponds to a single gene. 
 
Figure S5.   Analysis of trans-acting elements that regulate the axonal 
translatome, Related to Figure 5 (A) Ingenuity pathway analysis (IPA) to identify 
upstream regulators associated with the axonal translatome. The abundance of each 
mRNA between two consecutive stages was represented as the ratio (ratio > 1 
indicates increase in translation). The coordinate change in the translation ratios was 
calculated as the activation z-score. A positive z-score indicates that the translational 
regulator is expected to be activated. (B) Bar graph representing the fold change in 
levels of axonally translated genes. The mRNA levels in the axonal translatome were 
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quantified by qRT-PCR (normalized by TRAPed cDNA for each stage). (C) Density 
plots showing the distribution of changes in FPKM values for the axonal translatome 
during two consecutive developmental stages with p-values (Komogorov-Smirnov 
test). The values are calculated as follows: log2 (stage A(FPKM) / stage B (FPKM)). 
The distributions of target genes in pathways, which are indicated by colored lines, 
are overlapped with non-target genes represented by grey line. (D) A scatter plot of 
the Principal Component Analysis (PCA) based on normalized read counts in the 
axonal and retinal translatome from four different stages. Data were plotted using the 
first two Principal Components (PCs), which explained up to 73.2% of the total 
variance. (E) Relationship between transcript abundance of the genes in E17.5 
transcriptome, which were detected in E17.5 axonal translatome, and probability of 
their translation at later stages (blue line, mRNA level in transcriptome; red line, 
moving averages of percentage of genes detected at any of three later stages over a 
window size of 100 genes; r, Pearson correlation coefficient). The right heatmap 
show mRNA abundance in the translatome (left) and enriched pathways (right).  
 
Figure S6. Analysis for alternative isoforms and cis-acting elements, Related to 
Figure 6  (A-B) Sequence reads (grey bars) mapped on the genes, sarm1 (A) and 
clta (B). The mapped reads are visualized by Integrative Genomics Viewer (IGV) 
(C) Sequence reads (grey bars) mapped on the rhobtb3 (upper panel). Sanger 
sequencing of RT-PCR fragment of the ankrd1 (lower panel).  
 
Figure S7. Cis-regulatory elements for axonal translation, Related to Figure 7 
(A) Lists of sequence motifs enriched in 5’UTRs, 3’UTRs and alternative exons of 
axon-enriched mRNAs / exons. (B) An example of axon-enriched motifs. The 
scatterplot compares the normalized mRNA levels (log2(FPKM)) between the axonal 
(y axis) and the retinal (x axis) translatome at stage P0.5 for genes with (red dots) 
and without (black dots) the motif. The density plot shows the distribution of log2 
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(axon (FPKM) / retina (FPKM)). (C) GO enrichment analysis for entire genome 
containing axon-specific sequence motifs (K: G or T; R: A or G; Y: C or T; M: A or C; 
R: A or G; and H A or C or T) and their relative efficiency in axonal mRNA translation 
measured by fluorescence recovery after photobleaching (FRAP) of motif-containing 
reporter constructs (myr-d2EGFP). Several axon-specific motifs were able to 
promote mRNA translation in the growth cone relative to a control myr-d2EGFP 
construct without a UTR. Statistical significance of FRAP compared to the no-UTR 
control was tested across all time-points (0-10mins) using a two-way ANOVA (from 
the top bar, n=16, 5, 5, 7, 8, 7, 3, 8, 8, 8, 5, 8, and 6, respectively). For representative 
purposes, the mean fluorescence recovery at 10 minutes post-photobleaching is 
shown. Error bars represent SEM. **p<0.01, and ***<p0.001 compared to no-UTR 
control. 
 
Table S1. Axonally translating mRNAs, Related to Figure 3 
 
Table S2. Neuron-related GO terms, Related to Figure 4 
 
Table S3. GO term and motif analysis, Related to Figure 5 
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 intracellular non-membrane-bounded organelle4.E-06 1.4
11  perinuclear region of cytoplasm 6.E-06 2.8
12  actin cytoskeleton 2.E-05 2.6
13  endomembrane system 3.E-05 1.9
14  synapse part 4.E-05 2.5
15  microtubule cytoskeleton 4.E-05 1.9
16  Golgi apparatus 2.E-04 1.7
17  axon 2.E-04 3.1
18  microtubule 3.E-04 2.2
Axon-enriched mRNAs 
1  cytoskeleton 8.E-10 1.9
2  vesicle 4.E-08 2.2
3  cytoplasmic vesicle 1.E-07 2.2
4  neuron projection 4.E-07 2.7
5  cytoplasmic membrane-bounded vesicle 2.E-06 2.2
6  synapse 2.E-06 2.4
7  cytoskeletal part 3.E-06 1.8
8  membrane-bounded vesicle 3.E-06 2.1
9  non-membrane-bounded organelle 4.E-06 1.4
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Ranking  Term p-value Foldenrichment
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log2(FPKM)
-10 0 5 10-5
1.99 0.00 0.00 0.00 0.00 GO:0022615 protein to membrane docking 
2.03 0.04 0.00 0.00 0.00 GO:0000394 RNA splicing, via endonucleolytic cleavage and ligation 
2.71 0.06 0.00 0.00 0.00 GO:0032456 endocytic recycling 
2.71 0.01 0.06 0.00 0.00 GO:0090128 regulation of synapse maturation 
2.16 0.00 0.08 0.19 0.00 GO:1990089 response to nerve growth factor 
2.32 0.13 0.00 0.00 0.00 GO:1901021 positive regulation of calcium ion transmembrane transporter activity 
1.64 0.00 0.11 0.23 0.00 GO:1902003 regulation of beta-amyloid formation 
1.95 0.01 0.09 0.26 0.00 GO:0043113 receptor clustering 
3.62 0.16 0.00 0.03 0.00 GO:0008277 regulation of G-protein coupled receptor protein signaling pathway 
1.91 0.13 0.13 0.02 0.00 GO:0019722 calcium-mediated signaling 
3.26 0.00 0.40 0.06 0.06 GO:0048167 regulation of synaptic plasticity 
2.38 0.20 0.09 0.06 0.01 GO:0007268 synaptic transmission 
3.23 0.00 0.02 0.36 0.29 GO:0010038 response to metal ion 
3.03 0.01 0.48 0.10 0.01 GO:0031175 neuron projection development 
4.21 0.53 0.00 0.07 0.01 GO:0016192 vesicle-mediated transport 
1.68 0.04 0.62 0.12 0.01 GO:0048858 cell projection morphogenesis 
2.25 0.26 0.01 0.08 0.09 GO:0006897 endocytosis 
3.33 0.00 0.51 0.12 0.05 GO:0048666 neuron development 
2.22 0.80 0.00 0.04 0.06 GO:0015031 protein transport 
0.00 1.35 2.43 0.01 0.01 GO:0006412 translation 
0.00 0.84 0.60 0.16 1.62 GO:0044237 cellular metabolic process 
0.00 0.30 1.07 0.99 2.20 GO:0009058 biosynthetic process 
0.00 0.07 1.58 2.41 2.11 GO:0010467 gene expression 
0.00 0.02 0.76 2.01 3.24 GO:0032774 RNA biosynthetic process 
0.00 0.01 0.87 2.23 3.24 GO:0006355 regulation of transcription, DNA-templated 
0.00 0.18 0.39 0.96 2.70 GO:0006366 transcription from RNA polymerase II promoter 
0.12 0.03 0.33 0.83 1.68 GO:0008380 RNA splicing 
0.17 0.14 0.17 0.19 1.54 GO:0006401 RNA catabolic process 
0.07 0.08 0.28 0.41 1.90 GO:0060070 canonical Wnt signaling pathway 
0.06 0.00 0.71 0.87 1.63 GO:0072089 stem cell proliferation 
0.26 0.00 1.30 0.50 2.09 GO:0050658 RNA transport 
0.10 0.06 0.04 0.59 4.18 GO:0001654 eye development 
0.35 0.00 0.13 0.34 1.98 GO:0003407 neural retina development 
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 mTOR-signaling 
 Regulation of eIF4 and P70SK6 Signaling 
 EIF2 Signaling 
Translational control (3/8) 
 GABA receptor signaling 
 Glutamate Degradation III 
 Neurotrophin/TRK Signaling 
 Choline Degradation I 
 STAT3 pathway 
 Serotonin Receptor Signaling 
 Calcium Transport I 
Synapse function (7/16) 
 Semaphorin Signaling in Neurons 
 Ephrin Receptor Signaling 
 Ephrin B Signaling 
 Axonal Guidance Signaling 
Signaling for axon guidance (4/35) 
CREB Signaling in Neurons 
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Upstream 
regulators 
z-score 
Type Target mRNAs to 
P0.5 
to 
P7.5 
to 
Adult 
mTOR 1.86     kinase 
ACACA,ATG12,CACTIN,CASP3,CASP9,CCND1,CDKN1A,COX4I1,CS,ENO1,
FAF1,FASN,FKBP1A,FN1,FOXP3,GLUD1,HADHA,INHA,MADD,MAPT,MDM2
,NFKBIL1,PIP5K1C,PPARGC1B,PPP2CA,RBM5,RXRB,SMPD1,TCF4,TSC2 
FMR1 0.08 2.49 0.35 RNA-binding protein 
AGAP1,ALDOA,Ap2b1,APP,ATPIF1,BASP1,CEND1,CFL1,CTNNB1,ENO1,RA
B3A,RPSA,SYP,TSC2,UQCRQ 
miR-1 -1.74 1.37 2.22 microRNA ANXA2,ATP6V0A1,CASP3,CCND2,FN1,HSPD1,IGF1R,LASP1,MKL1,MTX1,PAX7,TAGLN2 
IREB2 -1.45 2.19 0.71 RNA-binding protein ACO2,APP,FTH1,FTL,SDHB 
Histogram of rbp_1r
rbp_1r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_2r
rbp_2r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_3r
rbp_3r
De
ns
ity
10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_1r
rbp_1r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_2r
rbp_2r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_3r
rbp_3r
De
ns
ity
10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_ r
rbp_1r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_2r
rbp_2r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_3r
rbp_3r
De
ns
ity
10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_1r
rbp_1r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_2r
rbp_2r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_3r
rbp_3r
De
ns
ity
10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_1r
rbp_1r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_2r
rbp_2r
De
ns
ity
20 10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
Histogram of rbp_3r
rbp_3r
De
ns
ity
10 0 10 20
0.
00
0.
05
0.
10
0.
15
0.
20
m
TO
R
 
FM
R
P 
A
P
C
 
TD
P
-4
3 
FU
S
 
P0.5/E17.5 P7.5/P0.5 Adult/P7.5 
p = 7e-08 p = 8e-04 
p = 2e-07 p = 5e-03 
p = 4e-07 p = 2e-07 
p = 1e-02 
p = 7e-01 
p = 8e-07 
p = 7e-02 p = 2e-02 p = 4e-01 
p = 6e-01 p = 8e-01 p = 2e-01 
4
2
0
2
4
6
5 0 5 10 15
daotx
da
ot
y
mTOR 
FMRP 
APC 
TDP-43 
FUS 
Others 
80% confidence ellipse 
PC1 
P
C
2 
Figure S5 
0
1
2 
3
4
5
6
0 
20
40
60
80
100
detected    weak   not detected 
detected 
r=0.33 
m
R
N
A level
(early transcriptom
e)
%
 o
f m
R
N
A
s 
tra
ns
la
te
d
at
 la
te
r s
ta
ge
s 
(P
0.
5-
ad
ul
t)
E17.5 translatome
E17.5 transcriptome
mRNA translated at
early stages
E
17
.5
 
P
0.
5 
P
7.
5 
A
du
lt 
E
17
.5
 
P
0.
5 
P
7.
5 
A
du
lt 
Axon         Retina 
log2(FPKM)
-10 0 5 10-5
A
C D
B
E
0 
1 
2 
3 
4 
5 
6 
Gl
ud
1 
Ma
pt 
Rp
s5
 
Ts
c2
 
Cf
l1 
Ald
oa
 
At
p5
 
Ba
sp
1 
Ce
nd
1 
E17.5 
P0.5 
P7.5 
Adult 
0 1.3
-log2(p-value)E17.5 P0.5 P7.5 Adult
Oxidative Phosphorylation 12.6 12.5 8.35 11
Mitochondrial Dysfunction 11.7 10.9 7.95 8.34
EIF2 Signaling 7.81 8.65 6.7 5.34
Pathway (E17 transcriptome) Translating stage 13
R
el
at
iv
e 
m
R
N
A
 a
m
ou
nt
(n
or
m
al
iz
ed
 to
 E
17
.5
)
Supplemental Figure 5 &liFN Kere tR GRZnlRaG Supplemental Figure
IigureBS5B5YBrrpGI
1 2   3                                   4       5   6           7              8                     9  10  11 12 
Circular RNA (back splicing 
from exon 7 to exon 3) 
Rhobtb3 
Exon 8 Exon 2 Ankrd12 
B Axon-specific back splicing events
A Clta isoforms (exon-skipping)
Re
tin
a
Ax
on
axon-absent isoform
axon-absent isoform
R
et
in
a
A
xo
n
Figure S6 
axon-dominant isoform
Supplemental Figure 6 &liFN Kere tR GRZnlRaG Supplemental Figure
FigureBS6B5YBrpGI
Figure S7 
A
5’-UTR 3’-UTR Alternative exon
B
C
GGAKTGTTCG 
GGCRYCGGCAGC 
GCTTYTMRCCCT 
RGTGTATCTT 
CTGATCAHHT 
KCTGAGRGYKTA 
CRACACRGGAAC 
ATGCCGGGAG 
GMCAACTCAGMT 
GCYCGCTTGC 
CCACYTGTTC 
ACTTYYCAGGGT 
RANDOM 
5’ UTR
3’ UTR
Consensus motif
identified by
HOMER
GO enrichment of 
motif-containing
genes in the genome
axon/synapse
-related GOs
Fluorescence recovery after photobleaching (FRAP)
Axonal mRNA translation
0 0.20.1 0.3
axon extension
axon guidance
synaptic transm
ission
regulation of synpatic plasticity
system
 process
im
m
une response
cell proliferation
Found in
axon-enriched
mRNAs in
(no motif control)
***
***
***
**
***
Log2(axon_FPKM/eye_FPKM) 
Eye 
A
xo
n 
Motif containing 
Others 
Motif containing 
Others 
( / ) 
 
A
xo
n 
tif t i i  
t r  
tif t i i  
t r  
Log2(axon_FPKM/eye_FPKM) 
Eye 
A
xo
n 
Motif containing 
Others 
Motif containing 
Others 
Motif-containing 
 
Others 
Supplemental Figure  &liFN Kere tR GRZnlRaG Supplemental Figure
FigureBSB5YBrpGI
